drugset / Trial / NCT03192735
Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
We star a multicentre, one-armed, clinical pilot trial intends to investigate the safety and effectiveness of Apatinib Combined With Oxaliplatin, Gimeracil and Oteracil Porassium Capsules Neoadjuvant Ttherapy for Locally Advanced Gastric Cancer(cT2-4/N+M0)
Timeline
- Start
- 2017-09-01
- Primary completion
- 2019-11-11
- Completion
- 2024-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gimeracil and Oteracil | Unknown | 40 mg | Oral |
| Subject | Gimeracil and Oteracil | Unknown | 50 mg | Oral |
| Subject | Gimeracil and Oteracil | Unknown | 60 mg | Oral |
| Subject | Oxaliplatin | Small molecule | 130 mg/m2 | Intravenous |
| Subject | Rivoceranib | Small molecule | 500 mg | Oral |